Shield Therapeutics PLC Stock
Price
Target price
?
?
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Shield Therapeutics PLC Stock
The Shield Therapeutics PLC price is unchanged compared to yesterday.
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 0.000% | 0.000% | -21.019% | 129.630% | -40.952% | -13.889% | -90.746% |
| Card Factory plc | -1.680% | -4.813% | -3.914% | -35.155% | -6.316% | -33.083% | -10.440% |
| Pets At Home Group Ls 1 | -0.910% | -2.437% | 1.502% | -33.436% | -5.836% | -51.998% | -57.608% |
| Natural Grocers By Vit. Cot. | 0.810% | -2.381% | 0.820% | -39.109% | 14.953% | 148.485% | 158.947% |
News
Exagen Q1 Earnings Call Highlights
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated